GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Cyclically Adjusted PB Ratio

Medrx Co (TSE:4586) Cyclically Adjusted PB Ratio : 0.69 (As of Jun. 23, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medrx Co Cyclically Adjusted PB Ratio?

As of today (2024-06-23), Medrx Co's current share price is 円165.00. Medrx Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was 円237.97. Medrx Co's Cyclically Adjusted PB Ratio for today is 0.69.

The historical rank and industry rank for Medrx Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

TSE:4586' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.31   Med: 0.52   Max: 1.03
Current: 0.69

During the past years, Medrx Co's highest Cyclically Adjusted PB Ratio was 1.03. The lowest was 0.31. And the median was 0.52.

TSE:4586's Cyclically Adjusted PB Ratio is ranked better than
81.67% of 753 companies
in the Drug Manufacturers industry
Industry Median: 1.87 vs TSE:4586: 0.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Medrx Co's adjusted book value per share data for the three months ended in Mar. 2024 was 円47.839. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円237.97 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medrx Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Medrx Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co Cyclically Adjusted PB Ratio Chart

Medrx Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.32 0.60

Medrx Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.63 0.57 0.60 0.60 0.58

Competitive Comparison of Medrx Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medrx Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medrx Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medrx Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Medrx Co's Cyclically Adjusted PB Ratio falls into.



Medrx Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Medrx Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=165.00/237.97
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medrx Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Medrx Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=47.839/107.2000*107.2000
=47.839

Current CPI (Mar. 2024) = 107.2000.

Medrx Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 587.727 98.000 642.901
201409 553.881 98.500 602.802
201412 525.300 97.900 575.201
201503 506.115 97.900 554.193
201506 476.337 98.400 518.936
201509 448.311 98.500 487.908
201512 402.410 98.100 439.739
201603 382.596 97.900 418.941
201606 343.635 98.100 375.511
201609 327.887 98.000 358.668
201612 294.375 98.400 320.701
201703 272.664 98.100 297.957
201706 239.236 98.500 260.366
201709 212.178 98.800 230.217
201712 228.811 99.400 246.766
201803 293.620 99.200 317.299
201806 277.419 99.200 299.792
201809 241.365 99.900 259.002
201812 208.594 99.700 224.286
201903 187.005 99.700 201.073
201906 187.471 99.800 201.372
201909 161.412 100.100 172.861
201912 140.062 100.500 149.399
202003 129.395 100.300 138.297
202006 104.928 99.900 112.595
202009 104.867 99.900 112.530
202012 110.495 99.300 119.286
202103 98.910 99.900 106.138
202106 94.916 99.500 102.261
202109 92.548 100.100 99.112
202112 79.507 100.100 85.146
202203 71.558 101.100 75.876
202206 64.202 101.800 67.608
202209 54.883 103.100 57.066
202212 42.967 104.100 44.247
202303 37.538 104.400 38.545
202306 47.729 105.200 48.636
202309 56.899 106.200 57.435
202312 50.169 106.800 50.357
202403 47.839 107.200 47.839

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medrx Co  (TSE:4586) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Medrx Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Medrx Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medrx Co (TSE:4586) Business Description

Traded in Other Exchanges
N/A
Address
431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co (TSE:4586) Headlines

No Headlines